CY1107923T1 - Τυποποιησεις ελεγχομενης απελευθερωσης χορηγουμενες απο του στοματος - Google Patents

Τυποποιησεις ελεγχομενης απελευθερωσης χορηγουμενες απο του στοματος

Info

Publication number
CY1107923T1
CY1107923T1 CY20081100432T CY081100432T CY1107923T1 CY 1107923 T1 CY1107923 T1 CY 1107923T1 CY 20081100432 T CY20081100432 T CY 20081100432T CY 081100432 T CY081100432 T CY 081100432T CY 1107923 T1 CY1107923 T1 CY 1107923T1
Authority
CY
Cyprus
Prior art keywords
controlled release
storage specifications
coating
pharmaceutical composition
active agent
Prior art date
Application number
CY20081100432T
Other languages
English (en)
Inventor
Rajen Shah
Satish Chandra Khanna
Oskar Kalb
Jorg Ogorka
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10861819&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1107923(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY1107923T1 publication Critical patent/CY1107923T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Μια φαρμακευτική σύνθεση ικανή να απελευθερώσει μια θεραπευτικά αποτελεσματική δόση ενεργού παράγοντα, π.χ., ριβαστιγμίνη, με χρονικά ελεγχόμενο τρόπο. Η φαρμακευτική σύνθεση περιλαμβάνει έναν πυρήνα που περιέχει φαρμακολογικά ενεργό παράγοντα, και μια επίστρωση όπου εδώ η επίστρωση περιλαμβάνει ένα εξωτερικό λεπτό στρώμα και ένα εσωτερικό λεπτό στρώμα, με το εσωτερικό να έχει τη μορφή μεμβράνης που είναι ημιδιαπερατή στο νερό και στα σωματικά υγρά.
CY20081100432T 1999-09-29 2008-04-17 Τυποποιησεις ελεγχομενης απελευθερωσης χορηγουμενες απο του στοματος CY1107923T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9923045.0A GB9923045D0 (en) 1999-09-29 1999-09-29 New oral formulations
EP00971290A EP1216032B1 (en) 1999-09-29 2000-09-27 Oral controlled release formulations

Publications (1)

Publication Number Publication Date
CY1107923T1 true CY1107923T1 (el) 2013-09-04

Family

ID=10861819

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100432T CY1107923T1 (el) 1999-09-29 2008-04-17 Τυποποιησεις ελεγχομενης απελευθερωσης χορηγουμενες απο του στοματος

Country Status (31)

Country Link
US (2) US20060246101A1 (el)
EP (1) EP1216032B1 (el)
JP (1) JP2003510268A (el)
KR (2) KR20050100710A (el)
CN (1) CN1213737C (el)
AR (1) AR025792A1 (el)
AT (1) ATE384517T1 (el)
AU (1) AU769646B2 (el)
BR (1) BR0014440A (el)
CA (1) CA2379595A1 (el)
CO (1) CO5210867A1 (el)
CY (1) CY1107923T1 (el)
CZ (1) CZ301455B6 (el)
DE (1) DE60037897T2 (el)
DK (1) DK1216032T3 (el)
EC (1) ECSP003685A (el)
ES (1) ES2299438T3 (el)
GB (1) GB9923045D0 (el)
HU (1) HUP0202744A3 (el)
IL (2) IL148908A0 (el)
MY (1) MY128759A (el)
NO (1) NO331480B1 (el)
NZ (1) NZ517335A (el)
PE (1) PE20010568A1 (el)
PL (1) PL200822B1 (el)
PT (1) PT1216032E (el)
RU (1) RU2281758C2 (el)
SK (1) SK286651B6 (el)
TR (1) TR200200683T2 (el)
WO (1) WO2001022944A1 (el)
ZA (1) ZA200202369B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY142204A (en) 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
CN101005830B (zh) 2004-08-13 2010-09-29 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放片剂、其制备方法及用途
NZ553645A (en) * 2004-08-13 2010-09-30 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
US8481565B2 (en) * 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
GB0606562D0 (en) * 2006-03-31 2006-05-10 Novartis Ag Organic compounds
CN101797236B (zh) * 2010-03-23 2012-05-23 西南大学 重酒石酸卡巴拉汀口腔崩解片及其制备方法
JP6173912B2 (ja) 2010-09-20 2017-08-02 エスピーアイ ファーマ，インコーポレイテッド マイクロカプセル化プロセスおよび製品
KR101990951B1 (ko) 2015-04-27 2019-06-20 주식회사 네비팜 리바스티그민 함유 서방출 의약조성물
CN106000294B (zh) * 2016-07-04 2019-04-30 三峡大学 一种高膨胀低收缩率膨润土及制备方法
CN115192538B (zh) * 2022-08-02 2023-09-15 沈阳信康药物研究有限公司 一种压制包衣型硝苯地平缓释片及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
IL74497A (en) * 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
NL195004C (nl) * 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
US4984807A (en) * 1990-01-12 1991-01-15 Baruch Shiryon Board game
US5229131A (en) * 1990-02-05 1993-07-20 University Of Michigan Pulsatile drug delivery system
EP0542926B1 (en) * 1990-08-07 1995-02-15 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
DE69425453T2 (de) * 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
US5962535A (en) * 1997-01-17 1999-10-05 Takeda Chemical Industries, Ltd. Composition for alzheimer's disease
AU7706598A (en) * 1997-05-30 1998-12-30 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
IL152330A0 (en) * 1997-07-01 2003-05-29 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
PT1121104E (pt) * 1998-10-01 2005-05-31 Novartis Ag Novas formulacoes orais de libertacao controlada
US6632451B2 (en) * 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system

Also Published As

Publication number Publication date
CN1376058A (zh) 2002-10-23
CO5210867A1 (es) 2002-10-30
US20060246101A1 (en) 2006-11-02
DE60037897T2 (de) 2008-12-24
EP1216032B1 (en) 2008-01-23
BR0014440A (pt) 2002-06-18
CZ20021028A3 (cs) 2002-06-12
SK286651B6 (sk) 2009-03-05
HUP0202744A3 (en) 2004-05-28
AU1019701A (en) 2001-04-30
SK4132002A3 (en) 2002-10-08
WO2001022944A1 (en) 2001-04-05
DK1216032T3 (da) 2008-06-02
IL148908A0 (en) 2002-09-12
ECSP003685A (es) 2002-05-23
ATE384517T1 (de) 2008-02-15
NO331480B1 (no) 2012-01-16
TR200200683T2 (tr) 2002-07-22
AU769646B2 (en) 2004-01-29
AR025792A1 (es) 2002-12-11
PL354075A1 (en) 2003-12-15
ZA200202369B (en) 2002-12-24
IL148908A (en) 2010-06-16
GB9923045D0 (en) 1999-12-01
CA2379595A1 (en) 2001-04-05
KR20050100710A (ko) 2005-10-19
NO20021452D0 (no) 2002-03-22
CN1213737C (zh) 2005-08-10
DE60037897D1 (de) 2008-03-13
CZ301455B6 (cs) 2010-03-10
EP1216032A1 (en) 2002-06-26
PT1216032E (pt) 2008-04-29
US20110038897A1 (en) 2011-02-17
ES2299438T3 (es) 2008-06-01
KR20020038778A (ko) 2002-05-23
RU2281758C2 (ru) 2006-08-20
JP2003510268A (ja) 2003-03-18
NO20021452L (no) 2002-03-22
PL200822B1 (pl) 2009-02-27
NZ517335A (en) 2003-10-31
HUP0202744A2 (hu) 2003-01-28
PE20010568A1 (es) 2001-05-29
MY128759A (en) 2007-02-28
KR100661441B1 (ko) 2006-12-27
WO2001022944A8 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
CY1107923T1 (el) Τυποποιησεις ελεγχομενης απελευθερωσης χορηγουμενες απο του στοματος
ES2275716T3 (es) Composicion farmaceutica de liberacion transdermica.
ES2149250T3 (es) Dispositivo para la administracion de medicamentos con liberacion controlada.
DK196189D0 (da) Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
DOP2001000229A (es) Forma de dosificación de fármaco activada por hidrogel
BR9815378A (pt) Sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório compreendendo sal de dietilamÈnio diclofenac e o método de fabricação do mesmo.
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
DK0949925T3 (da) Flad lægemiddelform til anbringelse i mundhulen med frigivelse der af buprenorphin eller et farmakologisk sammenligneligt stof, samt fremgangsmåde til fremstilling deraf
ID29530A (id) Sediaan obat-obatan untuk penggunaan eksternal menggunakan zat-zat non-steroid anti-peradangan dan analgesik
AR032293A1 (es) Estuche farmaceutico
NO993385L (no) Transdermalt terapeutisk system for avgivelse av hormoner
YU69096A (sh) Vodeni farmaceutski rastvor
PT1318792E (pt) Composicao de libertacao prolongada que contem claritromicina
PT1077703E (pt) Formas de medicamentos orais com libertacao reproduzivel da substancia activa gatifloxacina ou de seus sais ou hidratos farmaceuticamente aceitaveis
ATE469644T1 (de) Pharmazeutische zubereitung enthaltend n-ä2-(1,6, 7,8-tetrahydro-2h-indenoä5,4 büfuran-8- yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung
SV1998000119A (es) Formulacion medicamentosa con liberacion controlada de sustancia activa. ref. lea 32671-sv
DE69927374D1 (de) Entzündungshemmende pharmazeutische formulierungen
ES2143481T3 (es) Comprimido de valproato de sodio de liberacion lenta.
NO20012351L (no) Farmasoytisk sammensetning for modifisert frigjoring av insulinsensibiliserende middel
ES2195538T3 (es) Composicion farmaceutica que comprende una combinacion de isomeros dextro y levo de sotalol.
BR9910201A (pt) Sistema terapêutico transdérmico para emprego de candesartan
ES2188513T3 (es) Utilizacion de desoxipeganina para el tratamiento de la drogodependencia.
ATE258046T1 (de) Pharmazeutische, metamizol enthaltende brauseformulierung